Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | EMB-06 |
Trade Name | |
Synonyms | EMB06|EMB 06 |
Drug Descriptions |
EMB-06 is a bispecific antibody that targets B-cell maturation antigen (BCMA) expressed on tumor cells and CD3 on T-cells, potentially leading to activation of cytotoxic T-lymphocytes (CTL) and CTL-dependent killing of tumor cells expressing BCMA, and antitumor activity (NCI Drug Dictionary, Journal for ImmunoTherapy of Cancer 2023;11). |
DrugClasses | CD3 Antibody 107 TNFRSF17 Antibody 22 |
CAS Registry Number | NA |
NCIT ID | C179632 |